drugset / Trial / NCT03912805
ET-01 in Subjects With Lateral Canthal Lines, LCL-209
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).
Timeline
- Start
- 2019-02-27
- Primary completion
- 2019-05-06
- Completion
- 2019-10-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 1610 iu | Topical |